Normalizing the metabolic phenotype after myocardial infarction: Impact of subchronic high fat feeding

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 1, 2012, Pages 125-133

  Berthiaume, Jessica M ^a   Young, Martin E ^c   Chen, Xiaoqin ^a   McElfresh, Tracy A ^a   Yu, Xin ^b   Chandler, Margaret P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Cardiac metabolism; Coronary ligation; High fat; Metabolic substrate oxidation; Myocardial infarction; Pyruvate dehydrogenase; Pyruvate dehydrogenase kinase 4

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENERGY METABOLISM; ENZYME SYNTHESIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HEART WORK; LIPID DIET; MALE; NONHUMAN; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEMODYNAMICS; MALE; METABOLOME; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENOTYPE; PHOSPHOCREATINE; PHOSPHORYLATION; PROTEIN KINASES; PYRUVATE DEHYDROGENASE COMPLEX; RATS;

RATTUS NORVEGICUS;

EID: 84861986279     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.04.005     Document Type: Article

References (49)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Heart Disease and Stroke Statistics-2010 Update. A report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Bing R.J., Siegel A., Ungar I., Gilbert M. Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am J Med 1954, 16:504-515.
3. Bing R.J., Siegel A., Vitale A., Balboni F., Sparks E., Taeschler M., et al. Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart. Am J Med 1953, 15:284-296.
4. Lloyd S., Brocks C., Chatham J.C. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am J Physiol Heart Circ Physiol 2003, 285:H163-H172.
5. Shipp J.C., Thomas J.M., Crevasse L. Oxidation of carbon-14-labeled endogenous lipids by isolated perfused rat heart. Science 1964, 143:371-373.
6. Wisneski J.A., Gertz E.W., Neese R.A., Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987, 79:359-366.
7. Wittels B., Spann J.F. Defective lipid metabolism in the failing heart. J Clin Invest 1968, 47:1787-1794.
8. Ala-Rami A., Ylihautala M., Ingman P., Hassinen I.E. Influence of calcium-induced workload transitions and fatty acid supply on myocardial substrate selection. Metabolism 2005, 54:410-420.
9. van der Vusse G.J., Glatz J.F., Stam H.C., Reneman R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992, 72:881-940.
10. Hajri T., Ibrahimi A., Coburn C.T., Knapp F.F., Kurtz T., Pravenec M., et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 2001, 276:23661-23666.
11. Osorio J.C., Stanley W.C., Linke A., Castellari M., Diep Q.N., Panchal A.R., et al. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002, 106:606-612.
12. Lei B., Lionetti V., Young M.E., Chandler M.P., d'Agostino C., Kang E., et al. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol 2004, 36:567-576.
13. Pound K.M., Sorokina N., Ballal K., Berkich D.A., Fasano M., Lanoue K.F., et al. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ Res 2009, 104:805-812.
14. Mazer C.D., Stanley W.C., Hickey R.F., Neese R.A., Cason B.A., Demas K.A., et al. Myocardial metabolism during hypoxia: maintained lactate oxidation during increased glycolysis. Metabolism 1990, 39:913-918.
15. Brindley D.N., Kok B.P., Kienesberger P.C., Lehner R., Dyck J.R. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2011, 298:E897-E908.
16. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A 2003, 100:1226-1231.
17. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004, 18:1692-1700.
18. Chiu H.C., Kovacs A., Blanton R.M., Han X., Courtois M., Weinheimer C.J., et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005, 96:225-233.
19. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 66:1640-1649.
20. Ouwens D.M., Diamant M., Fodor M., Habets D.D., Pelsers M.M., El Hasnaoui M., et al. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 2007, 50:1938-1948.
21. Rennison J.H., McElfresh T.A., Okere I.C., Patel H.V., Foster A.B., Patel K.K., et al. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 2008, 79:331-340.
22. Berthiaume J.M., Bray M.S., McElfresh T.A., Chen X., Azam S., Young M.E., et al. The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. Am J Physiol Heart Circ Physiol 2010, 299:H410-H421.
23. Rennison J.H., McElfresh T.A., Okere I.C., Vazquez E.J., Patel H.V., Foster A.B., et al. High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol 2007, 292:H1498-H1506.
24. Rennison J.H., McElfresh T.A., Chen X., Anand V.R., Hoit B.D., Hoppel C.L., et al. Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol 2009, 46:883-890.
25. Christopher B.A., Huang H.M., Berthiaume J.M., McElfresh T.A., Chen X., Croniger C.M., et al. Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function. Am J Physiol Heart Circ Physiol 2010, 299:H1917-H1927.
26. Durgan D.J., Moore M.W., Ha N.P., Egbejimi O., Fields A., Mbawuike U., et al. Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate. Am J Physiol Heart Circ Physiol 2007, 293:H2385-H2393.
27. Morgan E.E., Faulx M.D., McElfresh T.A., Kung T.A., Zawaneh M.S., Stanley W.C., et al. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 2004, 287:H2049-H2053.
28. Pacher P., Nagayama T., Mukhopadhyay P., Batkai S., Kass D.A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008, 3:1422-1434.
29. Passonneau J.V., Lauderdale V.R. A comparison of three methods of glycogen measurement in tissues. Anal Biochem 1974, 60:405-412.
30. Taegtmeyer H., Hems R., Krebs H.A. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 1980, 186:701-711.
31. Goodwin G.W., Ahmad F., Doenst T., Taegtmeyer H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol 1998, 274:H1239-H1247.
32. Goodwin G.W., Arteaga J.R., Taegtmeyer H. Glycogen turnover in the isolated working rat heart. J Biol Chem 1995, 270:9234-9240.
33. Bak M.I., Ingwall J.S. NMR-invisible ATP in heart: fact or fiction?. Am J Physiol 1992, 262:E943-E947.
34. Hoult D.I., Busby S.J., Gadian D.G., Radda G.K., Richards R.E., Seeley P.J. Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 1974, 252:285-287.
35. Saddik M., Lopaschuk G.D. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991, 266:8162-8170.
36. Weiss R.G., Gerstenblith G., Bottomley P.A. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A 2005, 102:808-813.
37. Bottomley P.A., Wu K.C., Gerstenblith G., Schulman S.P., Steinberg A., Weiss R.G. Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation 2009, 119:1918-1924.
38. Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997, 96:2190-2196.
39. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996, 94:2837-2842.
40. Tuunanen H., Engblom E., Naum A., Nagren K., Hesse B., Airaksinen K.E., et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 2006, 114:2130-2137.
41. Murray A.J., Lygate C.A., Cole M.A., Carr C.A., Radda G.K., Neubauer S., et al. Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc Res 2006, 71:149-157.
42. Huang B., Wu P., Bowker-Kinley M.M., Harris R.A. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 2002, 51:276-283.
43. Holness M.J., Smith N.D., Bulmer K., Hopkins T., Gibbons G.F., Sugden M.C. Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Biochem J 2002, 364:687-694.
44. Chambers K.T., Leone T.C., Sambandam N., Kovacs A., Wagg C.S., Lopaschuk G.D., et al. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response. J Biol Chem 2011, 286:11155-11162.
45. Zhao G., Jeoung N.H., Burgess S.C., Rosaaen-Stowe K.A., Inagaki T., Latif S., et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 2008, 294:H936-H943.
46. Marketou M., Kintsurashvili E., Papanicolaou K.N., Lucero H.A., Gavras I., Gavras H. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. Am J Hypertens 2010, 23:562-568.
47. Connaughton S., Chowdhury F., Attia R.R., Song S., Zhang Y., Elam M.B., et al. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol 2010, 315:159-167.
48. Longnus S.L., Wambolt R.B., Barr R.L., Lopaschuk G.D., Allard M.F. Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol 2001, 281:H1561-H1567.
49. Belke D.D., Larsen T.S., Lopaschuk G.D., Severson D.L. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol 1999, 277:R1210-R1217.